<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR558.html">Part 558
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 558.325  Lincomycin.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications. Type A medicated articles containing 20 or 50 grams per pound lincomycin as lincomycin hydrochloride.</p><p class="depth0"><em>(b)</em> Sponsor. See No. 054771 in Sec. 510.600(c) of this chapter.</p><p class="depth0"><em>(c)</em> Related tolerances. See Sec. 556.360 of this chapter.</p><p class="depth0"><em>(d)</em> Special considerations--(1) Labeling of Type A medicated articles and Type B and Type C medicated feeds containing lincomycin shall bear the following directions: ``CAUTION: Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects.''</p><p class="depth0"><em>(1)</em> Labeling of Type A medicated articles and Type B and Type C medicated feeds containing lincomycin shall bear the following directions: ``CAUTION: Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects.''</p><p class="depth0"><em>(2)</em> Labeling of Type A medicated articles and Type B and Type C medicated feeds containing lincomycin intended for use in swine shall bear the following directions: ``CAUTION: Occasionally, swine fed lincomycin may within the first 2 days after the onset of treatment develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within 5 to 8 days without discontinuing the lincomycin treatment.''</p><p class="depth0"><em>(3)</em> Labeling of Type A medicated articles and single-ingredient Type B and Type C medicated feeds containing lincomycin intended for use in swine shall bear the following directions:</p><p class="depth0"><em>(i)</em> No. 054771: ``CAUTION: The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Not for use in swine intended for breeding when lincomycin is fed at 20 grams per ton of complete feed.''</p><p class="depth0"><em>(ii)</em> No. 051311:``CAUTION: Not to be fed to swine that weigh more than 250 lb.''</p><p class="depth0"><em>(e)</em> Conditions of use--(1) Chickens. It is used in feed as follows:
----------------------------------------------------------------------------------------------------------------</p><p class="depth0"><em>(i)</em> 2....................................  Broilers: For control of      As lincomycin hydrochloride      054771</p><p class="depth0">necrotic enteritis caused     monohydrate..</p><p class="depth0">by Clostridium spp. or</p><p class="depth0">other susceptible</p><p class="depth0">organisms..(ii) 2 to 4..............................  Broilers: For increased rate  As lincomycin hydrochloride      054771</p><p class="depth0">of weight gain and improved   monohydrate..</p><p class="depth0">feed efficiency..----------------------------------------------------------------------------------------------------------------</p><p class="depth0"><em>(2)</em> Swine. It is used in feed as follows:</p><p class="depth0">----------------------------------------------------------------------------------------------------------------</p><p class="depth0"><em>(i)</em> 20...................................  Growing-finishing swine: For  Feed as sole ration.........     054771</p><p class="depth0">increased rate of weight</p><p class="depth0">gain..(ii) 40..................................  1. For control of swine       Feed as sole ration; for use     054771</p><p class="depth0">dysentery..                   in swine on premises with a</p><p class="depth0">history of swine dysentery</p><p class="depth0">but where symptoms have not</p><p class="depth0">yet occurred, or following</p><p class="depth0">use of lincomycin at 100</p><p class="depth0">grams (g)/ton for treatment</p><p class="depth0">of swine dysentery..</p><p class="depth0">2. For control of porcine     Feed as sole ration, or          054771</p><p class="depth0">proliferative enteropathies   following use of lincomycin</p><p class="depth0"><em>(ileitis)</em> caused by           at 100 g/ton for control of</p><p class="depth0">Lawsonia intracellularis..    porcine proliferative</p><p class="depth0">enteropathies (ileitis)..(iii) 100................................  1. For treatment of swine     Feed as sole ration for 3        054771</p><p class="depth0">dysentery..                   weeks or until signs of</p><p class="depth0">disease disappear..</p><p class="depth0">2. For control of porcine     Feed as sole ration for 3        054771</p><p class="depth0">proliferative enteropathies   weeks or until signs of</p><p class="depth0"><em>(ileitis)</em> caused by           disease disappear..</p><p class="depth0">Lawsonia intracellularis..(iv) 200.................................  For reduction in the          Feed as sole ration for 3        054771</p><p class="depth0">severity of swine             weeks..</p><p class="depth0">mycoplasmal pneumonia</p><p class="depth0">caused by Mycoplasma</p><p class="depth0">hyopneumoniae..----------------------------------------------------------------------------------------------------------------</p><p class="depth0"><em>(3)</em> Lincomycin may also be used in combination with:</p><p class="depth0"><em>(i)</em> Amprolium and ethopabate as in Sec. 558.58.</p><p class="depth0"><em>(ii)</em> Clopidol as in Sec. 558.175.</p><p class="depth0"><em>(iii)</em> Decoquinate as in Sec. 558.195.</p><p class="depth0"><em>(iv)</em> Fenbendazole as in Sec. 588.258.</p><p class="depth0"><em>(v)</em> Halofuginone as in Sec. 558.265.</p><p class="depth0"><em>(vi)</em> Ivermectin as in Sec. 558.300.</p><p class="depth0"><em>(vii)</em> Lasalocid sodium as in Sec. 558.311.</p><p class="depth0"><em>(viii)</em> Monensin as in Sec. 588.355.</p><p class="depth0"><em>(ix)</em> Nicarbazin alone and with narasin as in Sec. 558.366.</p><p class="depth0"><em>(x)</em> Pyrantel as in Sec. 558.485.</p><p class="depth0"><em>(xi)</em> Robenidine as in Sec. 558.515.</p><p class="depth0"><em>(xii)</em> Salinomycin as in Sec. 558.550.</p><p class="depth0"><em>(xiii)</em> Zoalene as in Sec. 558.680.
[40 FR 13959, Mar. 27, 1975]</p><p class="depth0">Editorial Note: For Federal Register citations affecting Sec. 558.325, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at www.fdsys.gov.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
